New brain fluid drain device tested in tiny trial

NCT ID NCT06201429

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early study tests a device called Mechanical Tissue Resuscitation (MTR) that is designed to drain excess fluid from the brain area after a person has had part of their skull removed or repaired. The trial will include 11 people who need a drain as part of their standard care. The main goal is to see if the device is safe and can remove fluid without causing harm.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Mechanical Tissue Resuscitation (MTR) therapy system (a device that drains excess fluid from the brain area after skull surgery)
What this could lead to
If it works, this could offer a safer, more effective way to remove fluid after skull surgery, potentially reducing complications.
What could go wrong
This is a very early feasibility study with only 11 people, so it is not designed to prove effectiveness. The device may not work as hoped or could cause side effects like tissue damage or bleeding.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CLINICAL NEED FOR CRANIOPLASTY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Atrium Health Wake Forest Baptist

    RECRUITING

    Winston-Salem, North Carolina, 27157, United States

  • University at Buffalo Neurosurgery

    RECRUITING

    Buffalo, New York, 14203, United States

  • West Virginia University

    RECRUITING

    Morgantown, West Virginia, 26506, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.